Know sooner if you have cancer.
Unmatched accuracy.
Caris Detect™ analyzes every gene in the human body to find evidence of cancer sooner, and with the greatest accuracy available, so patients can act when it matters most.
NOW AVAILABLE*

WHY EARLY DETECTION MATTERS
Earlier cancer detection can change everything.
Caris Detect – the only multi-cancer early detection blood test that analyzes the entire genome – has the ability to detect cancer signals that other tests may miss, even at early stages of disease development.
Powered by advanced Al technology trained on 50 billion molecular markers from more than 1 million real patient cases, Caris Detect is rooted in one of the largest oncological datasets of its kind. Through this depth and breadth of real-world evidence, Caris Detect identifies cancer earlier – and with industry-leading accuracy.
| Stage | Sensitivity |
|---|---|
| Stage I | 56.8% |
| Stage II | 70.1% |
| Stage I-II Combined | 61.3% |
| Stage III | 77.1% |
| Stage IV | 99.1% |
Stop waiting. Start knowing.
The sooner you know, the more power you have to take action. Caris Detect identifies cancer signals before symptoms even appear, when patients still have the greatest number of options — and the most time to act.
Is Caris Detect right for you?
Know before symptoms decide for you.
Most cancers are found too late: after symptoms have appeared, disease has spread and options have narrowed. Caris Detect can find cancer signals in the blood as early as Stage I, when treatment options are greatest.

